Among the two families of known apoptosis regulators (IAP and Bcl-2 families of proteins), XIAP is considered the most potent inhibitor of cell death and an attractive therapeutic target due to its ability to suppress caspase activation via both intrinsic and extrinsic pathways and its ability to act as a signaling intermediate in tumor cell survival, immune and inflammatory pathways [17,44]. This evidence concerns the gene BCL2 and neoplasm.